59 related articles for article (PubMed ID: 15979100)
1. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
2. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
3. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J
Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295
[TBL] [Abstract][Full Text] [Related]
4. Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.
Wu J; Richards MH; Huang J; Al-Harthi L; Xu X; Lin R; Xie F; Gibson AW; Edberg JC; Kimberly RP
PLoS One; 2011; 6(10):e26143. PubMed ID: 22022540
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.
Gong L; Xia Y; Qian Z; Shi J; Luo J; Song G; Xu J; Ye Z
Oncol Lett; 2018 Apr; 15(4):5243-5249. PubMed ID: 29552163
[TBL] [Abstract][Full Text] [Related]
6. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
Emami KH; Nguyen C; Ma H; Kim DH; Jeong KW; Eguchi M; Moon RT; Teo JL; Kim HY; Moon SH; Ha JR; Kahn M
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12682-7. PubMed ID: 15314234
[TBL] [Abstract][Full Text] [Related]
7. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.
Luo NF; Li JL; Lv J; Chen FK; Li YN; Tang M; Liu PJ
Heliyon; 2024 Mar; 10(6):e27840. PubMed ID: 38545139
[TBL] [Abstract][Full Text] [Related]
8. A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma.
Lalli E
Front Endocrinol (Lausanne); 2023; 14():1303332. PubMed ID: 38155952
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin/Tcf7l2-dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer.
Zhao Z; Wang L; Bartom E; Marshall S; Rendleman E; Ryan C; Shilati A; Savas J; Chandel N; Shilatifard A
Sci Adv; 2019 Jul; 5(7):eaax0698. PubMed ID: 31392276
[TBL] [Abstract][Full Text] [Related]
10. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.
Mann B; Gelos M; Siedow A; Hanski ML; Gratchev A; Ilyas M; Bodmer WF; Moyer MP; Riecken EO; Buhr HJ; Hanski C
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1603-8. PubMed ID: 9990071
[TBL] [Abstract][Full Text] [Related]
11. Identification of c-MYC as a target of the APC pathway.
He TC; Sparks AB; Rago C; Hermeking H; Zawel L; da Costa LT; Morin PJ; Vogelstein B; Kinzler KW
Science; 1998 Sep; 281(5382):1509-12. PubMed ID: 9727977
[TBL] [Abstract][Full Text] [Related]
12. The origin and evolution of Wnt signalling.
Holzem M; Boutros M; Holstein TW
Nat Rev Genet; 2024 Feb; ():. PubMed ID: 38374446
[TBL] [Abstract][Full Text] [Related]
13. Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells.
Pavičić I; Rokić F; Vugrek O
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003292
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-495: a therapeutic and diagnostic tumor marker.
Maharati A; Tolue Ghasaban F; Akhlaghipour I; Taghehchian N; Zangouei AS; Moghbeli M
J Mol Histol; 2023 Dec; 54(6):559-578. PubMed ID: 37759132
[TBL] [Abstract][Full Text] [Related]
15. Novel
Panagopoulos I; Andersen K; Rinvoll Johannsdottir IM; Micci F; Heim S
Cancer Genomics Proteomics; 2023; 20(1):51-63. PubMed ID: 36581344
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Wnt in the transition from physiology to oncology.
Swoboda J; Mittelsdorf P; Chen Y; Weiskirchen R; Stallhofer J; Schüle S; Gassler N
World J Clin Oncol; 2022 Mar; 13(3):168-185. PubMed ID: 35433295
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway.
Neogi K; Murumkar PR; Sharma P; Yadav P; Tewari M; Karunagaran D; Nayak PK; Yadav MR
Transl Oncol; 2022 May; 19():101395. PubMed ID: 35325837
[TBL] [Abstract][Full Text] [Related]
18. NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice.
Guo F; Seldin M; Péterfy M; Charugundla S; Zhou Z; Lee SD; Mouton A; Rajbhandari P; Zhang W; Pellegrini M; Tontonoz P; Lusis AJ; Shih DM
Sci Rep; 2021 Aug; 11(1):16409. PubMed ID: 34385484
[TBL] [Abstract][Full Text] [Related]
19. Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing.
Xu Z; Gao G; Liu F; Han Y; Dai C; Wang S; Wei G; Kuang Y; Wan D; Zhi Q; Xu Y
Front Oncol; 2020; 10():1282. PubMed ID: 32850392
[No Abstract] [Full Text] [Related]
20. Nuclear Regulation of Wnt/β-Catenin Signaling: It's a Complex Situation.
Anthony CC; Robbins DJ; Ahmed Y; Lee E
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
